New Jersey: After Cannabis Legalization And Facing A Psilocybin Bill, Reluctance And Doubts Arise

The Psilocybin Behavioral Health Access and Services Act  sent by Senate President Nicholas Scutari to the Health, Human Services & Senior Citizens Committee several weeks ago, would legalize psilocybin’s production and use for mental health disorders such as depression, anxiety and end-of-life stress.   As Charles Toutant reports in the New Jersey Law Journal , the extended process to establish an infrastructure to produce & regulate cannabis has provided many opportunities for attorneys to participate. Now, some people call the current legislation vague, with respect to the procedure for obtaining medical approval for the use of psilocybin as well as other points.  For instance, former Burlington County prosecutor Scott Coffina said New Jersey had “a very tight medical marijuana system," while he is not sure whether he sees the same rigor in terms of demonstrating a need for the drug in the psychedelic mushrooms bill.  Coffina went on to explain his concerns over how the new legislation appears to be modeled on the medical marijuana law , yet the mechanism to qualify as a buyer and the role of the potential doctor supervising the treatment are unclear. He fears that the NJ psilocybin program could become like the ... Full story available on